142 related articles for article (PubMed ID: 10828018)
1. Smad7 selectively interferes with different pathways of activin signaling and inhibits erythroid leukemia cell differentiation.
Kitamura K; Aota Si; Sakamoto R; Yoshikawa SI; Okazaki K
Blood; 2000 Jun; 95(11):3371-9. PubMed ID: 10828018
[TBL] [Abstract][Full Text] [Related]
2. Smad7 is an activin-inducible inhibitor of activin-induced growth arrest and apoptosis in mouse B cells.
Ishisaki A; Yamato K; Nakao A; Nonaka K; Ohguchi M; ten Dijke P; Nishihara T
J Biol Chem; 1998 Sep; 273(38):24293-6. PubMed ID: 9733712
[TBL] [Abstract][Full Text] [Related]
3. Regulation and actions of Smad7 in the modulation of activin, inhibin, and transforming growth factor-beta signaling in anterior pituitary cells.
Bilezikjian LM; Corrigan AZ; Blount AL; Chen Y; Vale WW
Endocrinology; 2001 Mar; 142(3):1065-72. PubMed ID: 11181520
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.
Persson U; Souchelnytskyi S; Franzén P; Miyazono K; ten Dijke P; Heldin CH
J Biol Chem; 1997 Aug; 272(34):21187-94. PubMed ID: 9261125
[TBL] [Abstract][Full Text] [Related]
5. TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.
Piek E; Moustakas A; Kurisaki A; Heldin CH; ten Dijke P
J Cell Sci; 1999 Dec; 112 ( Pt 24)():4557-68. PubMed ID: 10574705
[TBL] [Abstract][Full Text] [Related]
6. Identification of receptors and Smad proteins involved in activin signalling in a human epidermal keratinocyte cell line.
Shimizu A; Kato M; Nakao A; Imamura T; ten Dijke P; Heldin CH; Kawabata M; Shimada S; Miyazono K
Genes Cells; 1998 Feb; 3(2):125-34. PubMed ID: 9605406
[TBL] [Abstract][Full Text] [Related]
7. Functional antagonism between activin and osteogenic protein-1 in human embryonal carcinoma cells.
Piek E; Afrakhte M; Sampath K; van Zoelen EJ; Heldin CH; ten Dijke P
J Cell Physiol; 1999 Aug; 180(2):141-9. PubMed ID: 10395283
[TBL] [Abstract][Full Text] [Related]
8. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects.
Yamashita H; ten Dijke P; Huylebroeck D; Sampath TK; Andries M; Smith JC; Heldin CH; Miyazono K
J Cell Biol; 1995 Jul; 130(1):217-26. PubMed ID: 7790373
[TBL] [Abstract][Full Text] [Related]
9. Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.
Cárcamo J; Weis FM; Ventura F; Wieser R; Wrana JL; Attisano L; Massagué J
Mol Cell Biol; 1994 Jun; 14(6):3810-21. PubMed ID: 8196624
[TBL] [Abstract][Full Text] [Related]
10. Levels of Smad7 regulate Smad and mitogen activated kinases (MAPKs) signaling and controls erythroid and megakaryocytic differentiation of erythroleukemia cells.
Akel S; Bertolette D; Petrow-Sadowski C; Ruscetti FW
Platelets; 2007 Dec; 18(8):566-78. PubMed ID: 18041647
[TBL] [Abstract][Full Text] [Related]
11. Engagement of activin and bone morphogenetic protein signaling pathway Smad proteins in the induction of inhibin B production in ovarian granulosa cells.
Bondestam J; Kaivo-oja N; Kallio J; Groome N; Hydén-Granskog C; Fujii M; Moustakas A; Jalanko A; ten Dijke P; Ritvos O
Mol Cell Endocrinol; 2002 Sep; 195(1-2):79-88. PubMed ID: 12354674
[TBL] [Abstract][Full Text] [Related]
12. Growth differentiation factor-9 signaling is mediated by the type I receptor, activin receptor-like kinase 5.
Mazerbourg S; Klein C; Roh J; Kaivo-Oja N; Mottershead DG; Korchynskyi O; Ritvos O; Hsueh AJ
Mol Endocrinol; 2004 Mar; 18(3):653-65. PubMed ID: 14684852
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation regulation of the interaction between Smad7 and activin type I receptor.
Liu X; Nagarajan RP; Vale W; Chen Y
FEBS Lett; 2002 May; 519(1-3):93-8. PubMed ID: 12023024
[TBL] [Abstract][Full Text] [Related]
14. Differential effect of activin A and BMP-7 on myofibroblast differentiation and the role of the Smad signaling pathway.
You L; Kruse FE
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):72-81. PubMed ID: 11773015
[TBL] [Abstract][Full Text] [Related]
15. Activin and inhibin have antagonistic effects on ligand-dependent heteromerization of the type I and type II activin receptors and human erythroid differentiation.
Lebrun JJ; Vale WW
Mol Cell Biol; 1997 Mar; 17(3):1682-91. PubMed ID: 9032295
[TBL] [Abstract][Full Text] [Related]
16. Two distinct signaling pathways activated by activin A in glucose-responsive pancreatic beta-cell lines.
Shibata H; Kanzaki M; Takeuchi T; Miyazaki J; Kojima I
J Mol Endocrinol; 1996 Jun; 16(3):249-58. PubMed ID: 8782083
[TBL] [Abstract][Full Text] [Related]
17. Truncated activin type II receptor inhibits erythroid differentiation in K562 cells.
Liu F; Shao LE; Yu J
J Cell Biochem; 2000 Apr; 78(1):24-33. PubMed ID: 10797563
[TBL] [Abstract][Full Text] [Related]
18. Regulation of Smad7 promoter by direct association with Smad3 and Smad4.
Nagarajan RP; Zhang J; Li W; Chen Y
J Biol Chem; 1999 Nov; 274(47):33412-8. PubMed ID: 10559222
[TBL] [Abstract][Full Text] [Related]
19. Activin A-induced HepG2 liver cell apoptosis: involvement of activin receptors and smad proteins.
Chen W; Woodruff TK; Mayo KE
Endocrinology; 2000 Mar; 141(3):1263-72. PubMed ID: 10698204
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic proteins.
Chen D; Zhao M; Mundy GR
Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
